Earnings Labs
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX)

NASDAQ·Healthcare·Biotechnology

$4.11

-4.31%

Mkt Cap $757.62M

Analyst Ratings

Buy

13

Hold

0

Sell

0

Price Target (20 analysts)

$11.60

Range $10.00$16.00

Implied Upside

+182.6%

Consensus $11.60 vs current $4.11